Trial Profile
Efficacy of 24 versus 48 weeks of peginterferon alfa 2a and ribivirin in patients with genotype 6 chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2012
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 10 Feb 2012 New trial record
- 17 Jan 2012 Results published in the Journal of Hepatology.